NMPA Approval

Emtricitabine and Tenofovir Alafenamide Fumarate Tablets(Ⅱ)

Approval Number

国药准字H20243934

Company石家庄龙泽制药股份有限公司

Registration Date

July 23, 2024

Drug Information

Generic Name

恩曲他滨丙酚替诺福韦片(Ⅱ)

Dosage Form

片剂

Strength

每片含200mg恩曲他滨，25mg丙酚替诺福韦

Drug Type

化学药品

Registration Date

July 23, 2024

Company Information

Applicant Company

Company Name石家庄龙泽制药股份有限公司

Company Address

深泽县工业园区（西环路16号）

Manufacturing Company

Company Name石家庄龙泽制药股份有限公司

Company Address

深泽县工业园区（西环路16号）

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

恩曲他滨丙酚替诺福韦片(Ⅱ) - NMPA 批准文号 | MedPath